Skip to main content

Swiss Lab Buys Partek's Genomics Lab for Epigenetic, Neurobio Studies

NEW YORK (GenomeWeb News) — The Friedrich Miescher Institute for Biomedical Research in Basel, Switzerland has bought Partek’s tiling and exon array data-handling software, Partek said yesterday.  
 
Partek said FMI’s Functional Genomics Lab will use its genomics suite software to analyze data from studies of epigenetics, growth control, and neurobiology.
 
Partek, based in St. Louis, Mo., is a genomics software developer specializing in an Affymetrix GeneChip-compatible platform used to identify and quantify data patterns.
 
Partek said its genomics suite handles data from “genomic and proteomic studies, high throughput-screening campaigns, and computer-aided drug design.”
 
Financial terms of the deal were not released.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.